Tuesday 25th

From 8am to 7pm:

  • 1×1 meetings between international investors, European biotech, medtech, digital health and pharmaceutical companies 
  • 1×1 meetings from Shangai & New York (video conference)

8am – 9:30am: 
Hot topic in oncology: beyond autologous CAR-T and ANTI-PD1 / ANTI-PD1-L1 … what’s next? 
Moderated by:
Claude Bertrand, Executive VP Research and Development – SERVIER
Wolf Hervé Fridman, Professor of immunology – UNIVERSITY PARIS DESCARTES
Véronique Blanc, Program Director Immune-Oncology Research – SERVIER
Fabrice Denis, Oncologist – CENTRE JEAN BERNARD
Joël Doré, Research Director – INRA
Alexander Eggermont, Managing Director – GUSTAVE ROUSSY INSTITUTE

9:30am – 10am: 
Partnering toward success
Serge WeinbergChairman of the Board of Directors – SANOFI
Hervé Brailly, Chairman – INNATE PHARMA 

10am – 10:30am: 
Networking break 

10:30am – 12am:
Synergies between business development and fund raising
Moderated by:
Eric Falcand, VP Global Head of Business Development & Licensing – SERVIER
Christian Policard, Senior Partner – BDC LIFESCIENCES
Nissim Darvish, Senior Managing Director – ORBIMED
David Lawrence, CFO – VALNEVA
Jongmoon Kim , CEO – TOOLGEN
Julie Puype, General Manager – TAKEDA France
Oded N Spindel, Ph.D., MBA, VP – H.C. Wainwright & Co, USA

12am – 1pm:
European strengths in Artificial Intelligence in Healthcare
Moderated by Francois Nicolas, Chief Digital Officer – GUERBET
– Nozha Boujemaa, Chief Science & Innovation Officer – MEDIAN TECHNOLOGIES
Achille Lerpinière, Head Project Manager at Health Data Hub, attached to the Ministry of Health
Françoise Simon, Professor University of Columbia & University of Nantes 
– Wim Van Hecke, CEO – ICOMETRIX 
Sebastien WoynarMD Director, Venture – LBO Ventures                                                                        

1pm – 2:15pm: 
Networking lunch 

2:15pm – 3:30pm:
Winning together: successful corporate and startup collaborations
Moderated by Paul Barrett – Facilitator 
Dr. Emilio Erazo-Fischer, MBA, Global BD & Licensing Oncology -BOEHRINGER  INGELHEIM 

Patrick Dey, VP, Global Head Digital Health & Innovation – AMGEN 
– Jean-Frederic Petit-Nivard, Pharma Development Director – OWKIN 

Sandrine Coulange, Health program Director – AXA Next
Marc Julien, CEO – DIABELOOP

Véronique Riethuisen, Sr VP, Global Head of Business Development & Alliance Management – IPSEN

3:30 – 4pm:
Networking break 

4pm – 5:30pm:
The American entrepreneurship model in Healthcare sciences: what are the best practices? 
Moderated by Pierre Courteille, Pharmacist & MBA Chicago Booth, CCO & VP BD – ABIVAX; VP – FRANCE BIOTECH
Gil Beyen, MBA, Chicago Booth; Chairman & CEO – ERYTECH PHARMA SA
Jeffrey Hubbell, Ph.D., Eugene Bell Professor in Tissue Engineering – UNIVERSITY OF CHICAGO
Sophie Kornowski, PhD & MBA, Chicago Booth; Senior Partner – GURNET POINT CAPITAL LLC
Starr Marcello, MBA, Chicago Booth; Deputy Head, Polsky Center for Entrepreneurship and Innovation; Assistant Professor of Entrepreneurship – UNIVERSITY OF CHICAGO
Melody Swartz, Ph.D., William B. Ogden Professor of Molecular Engineering – UNIVERSITY OF CHICAGO

5:30pm – 6pm:
The « Bridging Academia with Industry » model  
Moderated by Philippe Pouletty, co-founder & Managing Director- TRUFFLE CAPITAL
Gabriela Apiou, Ph.D., Director of Strategic Alliances – MASS GENERAL RESEARCH INSTITUTE & Assistant Professor of Dermatology – HARVARD MEDICAL SCHOOL 

Closing speech with: 
 – Maryvonne Hiance, Chairman FRANCE BIOTECH
 – Jean-Yves Le Drian, French Minister for Europe & Foreign Affairs (*)

From 6:30pm: 
Closing reception

(*) : To be defined
This program might be changed